Navigation Links
Cellulosic Biofuels Leader Qteros Adds Key Positions
Date:10/24/2009

programs. From 1996 through 2007, Mr. McLaughlin was with PRAECIS Pharmaceuticals, where as the company's first Chief Financial Officer he had responsibility for private financings, partnership financings, and the company's IPO and secondary stock offerings. In 2004, Mr. McLaughlin became COO and then President and CEO and member of the Board of Directors of PRAECIS and was responsible for negotiations resulting in the sale of the company to GlaxoSmithKline. Earlier in his career he spent 16 years in senior financial roles at Prime Computer and Computervision Corporation.

"Qteros is a fast-moving company with a solid foundation and a great deal of promise in a next-generation industry," said Mr. McLaughlin. "It's very exciting to join the company as it prepares for significant growth."

Mr. Lerner was most recently Vice President of Ventures and Business support for BP's chemicals business based in Shanghai, China, where he served on the Board of Directors and represented BP's shareholder interests in a large joint venture located outside of Shanghai. Prior to that role, he was based in the Chicago area, as general manager of a $600 million global chemical business with manufacturing facilities in the U.S., Canada, and Europe. Earlier in his career, he served as Vice President of Ventures and Development for BP Chemicals based in Hong Kong and Venture Development Manager for Amoco Corporation, as well as holding positions in finance and engineering.

"Throughout my career, I've led multi-functional teams that were focused on creating value through developing and implementing new strategies, projects, and commercial arrangements -- in businesses with a commodity focus and a global perspective," Lerner said. "Bringing that experience to Qteros, a cutting-edge energy company with national and international ties, allows me to apply my skills in one of today's most exciting industries."

Qteros is
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
2. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
3. Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
4. Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol
5. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
6. Verenium Announces First Commercial Cellulosic Ethanol Project
7. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
8. Dartmouth researchers advance cellulosic ethanol production
9. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
10. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
11. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cellulosic Biofuels Leader Qteros Adds Key Positions 
Cellulosic Biofuels Leader Qteros Adds Key Positions
(Date:12/11/2009)... BOULDER, Colo., December 10, 2009 miRagen Therapeutics, ... lives by developing innovative microRNA-based therapeutics for cardiovascular ... data demonstrating that microRNA-206 (miR-206) plays a crucial ... (ALS or Lou Gehrig,s disease) and in neuromuscular ... in the December 11 issue of the journal ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" ... and successfully harvested the elusive charges using ultra-thin solar ... efficiency, the authors report in the current online edition ... is captured in solar cells, it generates free electrons ... to snare these charges, the electrons must reach the ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
(Date:12/11/2009)... Mass., Dec. 11 Gwathmey, Inc., ... specializing in cancer, staph aureus, and cardiovascular disease ... Services announced today that Rosalie Dunn, Ph.D., has ... Dunn has over 28 years of experience working ... Prior to joining Gwathmey, Dr. Dunn managed multimillion ...
Breaking Biology Technology:miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... -- WuXi PharmaTech (NYSE:,WX), China,s premier provider of ... been nominated the winner of Deloitte,Technology Fast 50 ... technology,companies in China as recognized by Deloitte Touche ... The Deloitte Technology Fast 50 China program ...
... BERKELEY HEIGHTS, N.J., Oct. 18 Genta,Incorporated (Nasdaq: ... preclinical,data on Genasense(R) (oblimersen sodium) Injection, its lead ... and Therapeutics",conference that will take place from October ... is jointly sponsored by the U.S. National Cancer,Institute ...
... Nile Therapeutics,Inc. (OTC Bulletin Board: NILT.OB), a biopharmaceutical ... today that Mr.,Pedro Granadillo was appointed on October ... Mr. Granadillo is a highly-respected pharmaceutical industry,leader with ... human,resources, manufacturing and quality assurance. "We are ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia 2Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 2Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 3Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 2Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 3
(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...
(Date:12/15/2009)... and Ghent University in Flanders, Belgium have found an ... major cause of death in intensive care units. By ... mice with septic shock, researchers Anje Cauwels and Peter ... damage, while their chances of survival increased significantly. That,s ... that nitric oxide is responsible for the potentially lethal ...
(Date:12/15/2009)... German ., Despite the fact that ... cultures vary as to how space is encoded in ... terms such as ,left, right, front, back, to talk ... south, east, west, at all times for all scales: ... is an snake by your Northern leg". Whether not ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 1Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 2Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 3Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 1Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 2
... Scientists have discovered that a dominant hyena puts her ... born by passing on high levels of certain hormones ... sexually advanced. , The report, published in the April ... mammals to demonstrate a relationship between a female's social ...
... the brain immediately after a stroke may actually be beneficial ... could change the way stroke is treated, extending the window ... couple of weeks. The results may suggest new ideas for ... the Harvard Medical School Departments of Radiology and Neurology found ...
... a single study at the center of mounting support for ... children in poor countries. , The reviewers surveyed medical literature ... brand names for the generic medicine cotrimoxazole -- for children ... a person whose immune system is weakened by HIV. ...
Other Biology News:'Bad' enzymes may wear white hats after stroke 2'Bad' enzymes may wear white hats after stroke 3'Bad' enzymes may wear white hats after stroke 4Low-cost drug gaining favor for use in HIV-infected children in poor countries 2
... generated hybridomas against a large variety ... you are provided with personalized project ... lines developed by Covance remain exclusive ... hybridoma development project has four phases: ...
Cells are grown in triple flasks or roller bottles. Viability and growth data are generated from a parallel representative culture....
... The Human Genetic Cell Bank Service ... ECACC is based on Epstein-Barr Virus (EBV) ... resulting in the production of lymphoblastoid cell ... banked, providing a renewable and expandable source ...
... Extracts are optimized for maximum packaging efficiencies ... high efficiency extracts (> 109 pfu/g with ... a library containing at least 5 ... extracts are made from a specially designed ...
Biology Products: